CURRENT NEWS

• 20.02.2019
  Bausch Health Companies Inc. Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance
• 20.02.2019
  Henry Schein Reports Record Fourth Quarter and Full Year 2018 Financial Results
• 20.02.2019
  Proteostasis Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
• 20.02.2019
  Leronlimab (PRO 140) Reduces by More Than 98% Human Breast Cancer Metastasis in Mouse Xenografts for Over 6 Weeks
• 20.02.2019
  Rocket Pharmaceuticals Announces Participation in Fireside Chat at the 8th Annual SVB Leerink Global Healthcare Conference
• 20.02.2019
  FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA (Pembrolizumab) Monotherapy for Third-Line Treatment of Patients With Advanced Small Cell Lung Cancer (SCLC)
• 20.02.2019
  PPD and HLT to Create Data Science-Driven Clinical Research Solutions in China to Enhance Global Drug Development
• 20.02.2019
  Takeda Partners With Dundee University on Tau Pathology
• 20.02.2019
  Sandoz Launches Suboxone Generic in the USA
• 20.02.2019
  Intercept NASH Drug Closes in on FDA Approval
• 20.02.2019
  CannTrust to Start Trading on NYSE February 25
• 20.02.2019
  Sangamo Announces FDA Acceptance of IND Application for ST-920 Gene Therapy Candidate for Fabry Disease
• 20.02.2019
  ORIC Pharmaceuticals to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
• 20.02.2019
  BiomX Raises $32 Million in Series B Financing
• 20.02.2019
  Neovasc Provides Corporate Update
• 20.02.2019
  Canntab Provides Corporate Update
• 20.02.2019
  Alvogen Launches Generic Equivalent to Suboxone (Buprenorphine/Naloxone) Sublingual Film
• 20.02.2019
  Cannabis Growth Opportunity Corporation Announces NAV of $2.99
• 20.02.2019
  Biocept Issues Letter to Stockholders
• 20.02.2019
  Inovio Announces First Subject Dosed With Its DNA-Encoded Monoclonal Antibody (dMAb) in First-Ever Human Trial

Records per page:

Page

Total: 37016 records.